Copyright
©The Author(s) 2016.
World J Gastroenterol. Jan 28, 2016; 22(4): 1449-1460
Published online Jan 28, 2016. doi: 10.3748/wjg.v22.i4.1449
Published online Jan 28, 2016. doi: 10.3748/wjg.v22.i4.1449
Phenotype/function | Ref. reported increase | Ref. reported decrease | Ref. reported no change |
Activation marker | |||
CD69 | [34] | [88] | |
Activating receptor | |||
NKG2D | [34] | [68] | |
NKG2C | [77] | ||
NKp46 | [77,88,89] | [80] | |
NKp30 | [88] | [80] | |
NKp44 | [77] | ||
Inhibitory receptor | |||
KIR3DL1 | [34] | ||
NKG2A | [78-80] | ||
KLRG1 | [90] | ||
Cytotoxicity | |||
Degranulation | [34,77] | [68,80,89] | [78] |
TRAIL expression | [77] | [89] | |
Immunostimulating cytokine | |||
IFN-γ | [78] | [34,68] | [77,88] |
Immunosuppressive cytokine | |||
IL-10 | [88] |
- Citation: Yoon JC, Yang CM, Song Y, Lee JM. Natural killer cells in hepatitis C: Current progress. World J Gastroenterol 2016; 22(4): 1449-1460
- URL: https://www.wjgnet.com/1007-9327/full/v22/i4/1449.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i4.1449